|
EP3056568B1
(en)
|
2006-03-31 |
2021-09-15 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for controlling blood pharmacokinetics of antibodies
|
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
CN101874042B9
(zh)
|
2007-09-26 |
2019-01-01 |
中外制药株式会社 |
利用cdr的氨基酸取代来改变抗体等电点的方法
|
|
CA2721052C
(en)
|
2008-04-11 |
2023-02-21 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
|
|
PE20141162A1
(es)
|
2010-11-04 |
2014-09-18 |
Boehringer Ingelheim Int |
Anticuerpos anti-il-23
|
|
CN103328632A
(zh)
|
2010-11-30 |
2013-09-25 |
中外制药株式会社 |
与多分子的抗原重复结合的抗原结合分子
|
|
EP3524258B1
(en)
*
|
2011-06-22 |
2025-10-01 |
Apellis Pharmaceuticals, Inc. |
Methods of treating chronic disorders with complement inhibitors
|
|
SG10201605516YA
(en)
|
2011-07-06 |
2016-08-30 |
Nestec Sa |
Assays for detecting neutralizing autoantibodies to biologic therapy with tnf alpha
|
|
EP2583979B1
(en)
|
2011-10-19 |
2015-12-16 |
Effimune |
Methods to prepare antibodies directed against p19 subunit of human IL-23
|
|
KR102124758B1
(ko)
|
2012-05-03 |
2020-06-19 |
베링거 인겔하임 인터내셔날 게엠베하 |
항-ｉｌ-23ｐ19 항체
|
|
ES2718478T3
(es)
|
2012-06-08 |
2019-07-02 |
Sutro Biopharma Inc |
Anticuerpos que comprenden restos de aminoácidos no naturales de localización específica, métodos para su preparación y métodos para su uso
|
|
DK2863955T3
(en)
|
2012-06-26 |
2017-01-23 |
Sutro Biopharma Inc |
MODIFIED FC PROTEINS, INCLUDING LOCATION-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES THEREOF, METHODS OF PRODUCING ITS AND PROCEDURES FOR USE THEREOF
|
|
WO2014030750A1
(ja)
|
2012-08-24 |
2014-02-27 |
中外製薬株式会社 |
マウスFcγRII特異的Fc抗体
|
|
WO2014030728A1
(ja)
|
2012-08-24 |
2014-02-27 |
中外製薬株式会社 |
FcγRIIb特異的Fc領域改変体
|
|
AU2013308494B2
(en)
|
2012-08-31 |
2018-03-01 |
Sutro Biopharma, Inc. |
Modified amino acids comprising an azido group
|
|
SG11201502216UA
(en)
|
2012-09-24 |
2015-04-29 |
Medimmune Ltd |
Cell lines
|
|
EP2970949B1
(en)
|
2013-03-15 |
2018-05-30 |
MedImmune Limited |
Novel nucleic acid molecules
|
|
CN113621057A
(zh)
|
2013-04-02 |
2021-11-09 |
中外制药株式会社 |
Fc区变体
|
|
ES2865473T3
(es)
|
2013-07-10 |
2021-10-15 |
Sutro Biopharma Inc |
Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
|
|
EP3030545B1
(en)
|
2013-08-05 |
2020-10-07 |
MedImmune Limited |
Amino acid derivatives
|
|
JP6687247B2
(ja)
|
2014-05-10 |
2020-04-22 |
ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
化学的に固定された二重特異性抗体
|
|
WO2016014775A1
(en)
|
2014-07-24 |
2016-01-28 |
Boehringer Ingelheim International Gmbh |
Biomarkers useful in the treatment of il-23a related diseases
|
|
UA123624C2
(uk)
|
2014-09-03 |
2021-05-05 |
Бьорінґер Інґельхайм Інтернаціональ Ґмбх |
Сполука, специфічна до іл-23а та фнп-альфа, та її застосування
|
|
EP3227683B1
(en)
|
2014-12-05 |
2019-04-24 |
Nestec S.A. |
Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
|
|
IL278014B2
(en)
|
2014-12-19 |
2023-10-01 |
Chugai Pharmaceutical Co Ltd |
Anti-myostatin antibodies, polypeptides containing variable FC regions and methods of use
|
|
SG11201705728RA
(en)
|
2015-02-04 |
2017-08-30 |
Boehringer Ingelheim Int |
Methods of treating inflammatory diseases
|
|
SG10201907215QA
(en)
|
2015-02-05 |
2019-09-27 |
Chugai Pharmaceutical Co Ltd |
Antibodies Comprising An Ion Concentration Dependent Antigen-Binding Domain, Fc Region Variants, Il-8-Binding Antibodies, And Uses Therof
|
|
US10709839B2
(en)
|
2015-03-04 |
2020-07-14 |
Repro-Med Systems, Inc. |
Precision variable flow rate infusion system and method
|
|
US10906990B2
(en)
|
2015-08-19 |
2021-02-02 |
Riken |
Antibody with non-natural amino acid introduced therein
|
|
EP3394098A4
(en)
|
2015-12-25 |
2019-11-13 |
Chugai Seiyaku Kabushiki Kaisha |
ANTI-MYOSTATIN ANTIBODIES AND METHODS OF USE
|
|
CN106924754B
(zh)
*
|
2015-12-30 |
2021-11-09 |
北京大学 |
聚氨基酸偶联物
|
|
CA3011455A1
(en)
|
2016-01-27 |
2017-08-03 |
Sutro Biopharma, Inc. |
Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
|
|
CN109689099B
(zh)
|
2016-08-05 |
2023-02-28 |
中外制药株式会社 |
用于预防或治疗il-8相关疾病的组合物
|
|
WO2018119402A1
(en)
*
|
2016-12-23 |
2018-06-28 |
Visterra, Inc. |
Binding polypeptides and methods of making the same
|
|
KR102755136B1
(ko)
*
|
2017-05-09 |
2025-01-17 |
심리스 바이오로직스 게엠베하 |
변형된 마이크로시스틴 및 노둘라린
|
|
CN111727372A
(zh)
|
2017-10-13 |
2020-09-29 |
尤休尔股份有限公司 |
用于监测对核苷逆转录酶抑制剂疗法的遵守的产品和方法
|
|
CN110283249A
(zh)
*
|
2018-03-19 |
2019-09-27 |
江苏莱博德医疗科技有限公司 |
一种抗白介素6的人ScFv单链抗体
|
|
US20190292310A1
(en)
*
|
2018-03-20 |
2019-09-26 |
Northeastern University |
Synthesis of high density molecular dna brushes via organic-phase ring-opening metathesis (co)polymerization
|
|
IL279109B2
(en)
|
2018-05-31 |
2025-10-01 |
Glyconex Inc |
Biantennary therapeutic antibodies that bind Lewis B and Lewis Y antigens
|
|
WO2020077212A1
(en)
*
|
2018-10-11 |
2020-04-16 |
Amgen Inc. |
Downstream processing of bispecific antibody constructs
|
|
US20200405883A1
(en)
|
2019-06-20 |
2020-12-31 |
Baxalta Incorporated |
Method of treatment with viral-based gene therapy
|
|
CN113203863B
(zh)
*
|
2021-04-28 |
2022-01-21 |
北京美联泰科生物技术有限公司 |
一种适用于白介素-6检测的缓冲液
|
|
CN113150122B
(zh)
*
|
2021-05-19 |
2023-03-17 |
上海儒克生物科技有限公司 |
高通量全兔源单克隆抗体的制备方法
|
|
BR112023024494A2
(pt)
|
2021-05-24 |
2024-02-06 |
Humabs Biomed Sa |
Polipeptídeos engenheirados
|
|
CN115957319B
(zh)
*
|
2022-10-14 |
2023-06-30 |
北京东方百泰生物科技股份有限公司 |
一种抗nkg2a单克隆抗体的注射制剂
|
|
WO2025010424A1
(en)
|
2023-07-06 |
2025-01-09 |
Vir Biotechnology, Inc. |
Antibodies against staphylococcus antigens and methods of using the same
|
|
PL448731A1
(pl)
*
|
2024-05-31 |
2025-12-01 |
Celon Pharma Spółka Akcyjna |
Przeciwciała bispecyficzne anty–IL-17A i anty-IL-6 oraz ich zastosowanie w terapii, zwłaszcza w leczeniu chorób immunologicznych
|
|
CN120329434B
(zh)
*
|
2025-06-23 |
2025-10-21 |
杭州市第一人民医院(西湖大学附属杭州市第一人民医院) |
一种mfge8单克隆抗体及其制备方法和应用
|